David S. Ege - Executive Vice President and Chief Technology Officer at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President and Chief Technology Officer
Issuer Symbol
MCRB on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David S. Ege since 09 Mar 2025

Holdings reported by David S. Ege for Seres Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 77,575 $65,163 $0.8400 16 Aug 2024 Direct
Restricted Stock Units 29,688 $32,179 $1.08 15 Aug 2024 Direct Common Stock
Stock Option (Right to Buy) 287,905 14 Feb 2024 Direct Common Stock

Transactions reported by David S. Ege for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.